Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
H&D Wireless Sweden Holding B | HDWB | Mar 28, 2024 | 0.03 | +2.65 |
H&M B | HMB | Mar 28, 2024 | 174.58 | -1.78 |
HAKI Safety A | HAKIA | Mar 28, 2024 | 25.40 | 0.00 |
HAKI Safety B | HAKIB | Mar 28, 2024 | 25.40 | 0.00 |
Hamlet BioPharma AB (publ) | HAMLETB | Mar 28, 2024 | 1.70 | -2.86 |
Hansa Biopharma | HNSA | Mar 28, 2024 | 29.10 | -0.89 |
Hanza AB | HANZA | Mar 28, 2024 | 66.60 | +1.83 |
Harm Reduction Group | NOHARM | Mar 28, 2024 | 0.16 | +0.31 |
Havsfrun Investment | HAVS | Mar 28, 2024 | 15.50 | -0.39 |
Havsfrun Investment B | HAVB | Mar 28, 2024 | 15.50 | -0.39 |
Haypp Group | HAYPP | Mar 28, 2024 | 84.60 | +1.93 |
Headsent | VIMAB | Mar 28, 2024 | 9.80 | +1.55 |
Heba B | HEBAB | Mar 28, 2024 | 34.70 | +1.31 |
Hedera Group | HEGR | Mar 28, 2024 | 6.02 | +3.44 |
Heimstaden Pref | HEIMPREF | Mar 28, 2024 | 9.00 | +2.86 |
Heliospectra | HELIO | Mar 28, 2024 | 0.36 | 0.00 |
Hemnet Group | HEM | Mar 28, 2024 | 327.80 | -0.61 |
Hemply Balance | HMPLY | Mar 28, 2024 | 0.04 | -39.13 |
Hexagon B | HEXAB | Mar 28, 2024 | 126.70 | -0.43 |
Hexagon Purus | HPURO | Mar 28, 2024 | 5.93 | 0.00 |
Hexatronic Group | HTRO | Mar 28, 2024 | 32.92 | +0.06 |
Hexicon | HEXI | Mar 28, 2024 | 0.50 | 0.00 |
Hexpol B | HPOLB | Mar 28, 2024 | 130.60 | -2.32 |
Hifab B | HIFAB | Mar 28, 2024 | 2.50 | +1.63 |
High Coast Distillery B | HIGHCOB | Mar 28, 2024 | 44.90 | +4.66 |
Hilbert | HILBB | Mar 28, 2024 | 4.11 | 0.00 |
HMS Networks | HMS | Mar 28, 2024 | 463.60 | +0.74 |
Hoegh Autoliners ASA | HAUTOO | Mar 28, 2024 | 92.80 | 0.00 |
Hoi Publishing AB | HOIB | Mar 28, 2024 | 0.41 | 0.00 |
Hoist Finance | HOFI | Mar 28, 2024 | 53.10 | -0.93 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.